Inactivation of androgens by UDP-glucuronosyltransferases;L'inactivation des androgènes par les UDP-glucuronosyltransfé rases

Medecine/Sciences

Volumn 19, Issue 10, 2003, Pages 931-936

  Bélanger, Alain ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GLUCURONOSYLTRANSFERASE;

ENZYME INACTIVATION; ENZYME LOCALIZATION; ENZYME MECHANISM; GASTROINTESTINAL TRACT; KIDNEY PARENCHYMA; LIVER; PROSTATE; PROTEIN EXPRESSION; REVIEW; SKIN; STEROIDOGENESIS;

EID: 0141929470     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20031910931     Document Type: Review

References (24)

1. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999; 286: 487-91.
2. Tukey RH, Strassburg CP. Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol Phamacol 2001; 59: 405-14.
3. Lévesque E, Turgeon D, Carrier JS, Montminy V, Beaulieu M, Bélanger A. Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuonosyltransferase. Biochemistry 2001; 40: 3869-81.
4. Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 1999; 31: 817-99.
5. Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrinol Rev 2003; 24: 152-82.
6. Bélanger A, Brochu M, Cliche J. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. J Clin Endocrinol Metab 1986; 62: 812-5.
7. Brochu M, Bélanger A, Tremblay RR. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women. Fertil Steril 1987; 48: 948-53.
8. Green MD, Tephly TR. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metab Disp 1996; 24: 356-63.
9. Albert C, Vallée M, Beaudry G, Bélanger A, Hum DW. The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen conjugating enzymes. Endocrinology 1999; 140: 3292-302.
10. Beaulieu M, Lévesque E, Hum DW, Bélanger A. Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem Biophys Res Commun 1998; 248: 44-50.
11. Carrier JS, Turgeon D, Journeault K, Hum DW, Bélanger A. Isolation and characterization of the human UGT2B7 gene. Biochem Biophys Res Commun 2000; 272: 616-21.
12. Turgeon D, Carrier JS, Lévesque É, Hum DW, Bélanger A. Relative enzymatic activity, protein stability and tissue distribution of human steroid metabolizing UGT2B subfamily members. Endocrinology 2001; 142: 778-87.
13. Radominska-Pandya A, Little JM, Czernik PJ. Human UDP-glucuronosyltransferase 2B7. Curr Drug Metab 2001; 2: 283-98.
14. Gestl SA, Green MD, Shearer DA, Frauenhoffer E, Tephly TR, Weisz J. Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and alltrans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers. Am J Pathol 2002; 160: 1467-79.
15. Coumoul X, Barouki R. Génotoxicité des métabolites des cestrogènes et cancers. Med Sci 2002; 18: 86-90.
16. Turgeon D, Carrier JS, Lévesque E, Beatty BG, Bélanger A, Hum DW. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 2000; 295: 489-504.
17. Lévesque E, Beaulieu M, Green MD, Tephly TR, Bélanger A, Hum DW. Isolation and characterization of UGT2B15(Y85): A UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 1997; 7: 317-25.
18. Beaulieu M, Lévesque E, Hum DW, Bélanger A. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 1996; 271: 22855-62.
19. Horton R. Dihydrotestosterone is a peripheral paracrine hormone. J Androl 1992; 13: 23-7.
20. Bélanger A, Couture J, Caron S, Roy R. Determination of non-conjugated and conjugated steroid levels in plasma and prostate after separation on C-18 columns. Ann NY Acad Sci 1990; 595: 251-9.
21. El-Alfy M, Luu-The V, Huang XF, Berger L, Labrie F, Pelletier G. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and ondrogen receptor in the human prostate by in situ hybridization and immunohistochemistry. Endocrinology 1999; 140: 1481-91.
22. Barbier O, Lapointe H, El Alfy M, Hum DW, Belanger A. Cellular localization of uridine diphosphoglucuronosyltran sferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry. J Clin Endocrinol Metab 2000; 85: 4819-26.
23. MacLeod SL, Nowell S, Plaxco J, Lang NP. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol 2000; 7: 777-82.
24. Gsur A, Preyer M, Haidinger G, et al. A polymorphism in the UDP-glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 497-8.